XML 18 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities    
Net loss $ (48,218) $ (8,937)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 7,829 9,747
Amortization of debt issuance costs 1,273 1,292
Amortization of prior hedge effectiveness 3,076 1,094
Stock-based compensation 48,584 7,178
Impairment of long-lived assets 379 555
Impairment of investments   4,818
Loss on sale of business   1,764
Deferred income taxes (1,612) (1,755)
Change in fair value of financial guarantee (150) (1,000)
Change in fair value of derivative instruments 28 125
Unrealized foreign exchange (gain) loss (401) 2,498
Other 4 (5)
Changes in operating assets and liabilities, net of effects of disposal of business:    
Accounts receivable (2,308) (1,263)
Prepaid expenses and other current assets (1,693) (160)
Other assets (668) (186)
Accounts payable 7,891 13,478
Accrued expenses and other liabilities 3,195 (1,600)
Income tax payable (276) 12
Deferred revenue 23,763 21,665
Net cash provided by operating activities 40,696 49,320
Cash flows from investing activities    
Purchase of property and equipment (6,004) (4,491)
Sale of business, net of cash sold   (1,175)
Net cash used in investing activities (6,004) (5,666)
Cash flows from financing activities    
Repayment of capital lease obligations (16) (16)
Repayment of 2018 Term Loan (2,675) (2,675)
Proceeds from 2018 Revolving Facility   40,000
Repayment of 2018 Revolving Facility   (40,000)
Repayment of hybrid debt (1,332) (339)
Payment of initial public offering costs (2,794)  
Payment of contingent consideration (500)  
Payment of special dividends (47) (179)
Repurchases of common stock for tax withholding obligations (209) (2,813)
Proceeds from exercise of stock options, net of cash paid for employee tax withholding 327 93
Net cash used in financing activities (7,246) (5,929)
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalent 56 (243)
Net increase in cash, cash equivalents and restricted cash equivalent 27,502 37,482
Cash, cash equivalents and restricted cash equivalent, at beginning of the period 139,470 74,180
Cash, cash equivalents and restricted cash equivalent, at end of the period 166,972 111,662
Reconciliation of cash, cash equivalents, and restricted cash equivalent reported in the consolidated balance sheets    
Cash and cash equivalents 166,972 86,662
Restricted cash equivalent   25,000
Total cash, cash equivalents, and restricted cash equivalent shown in the condensed consolidated statements of cash flows 166,972 111,662
Non-cash investing and financing activities    
Purchase of property and equipment included in accounts payable and accrued expenses and other current liabilities 584 1,282
Change in fair value of hedged interest rate swaps and interest rate cap (3,133) 49
Transfer of interest rate swaps derivative liability to hybrid debt   $ 12,345
Deferred offering costs included in accounts payable and accrued expenses and other current liabilities 2,678  
Deferred financing costs included in accounts payable and accrued expenses and other current liabilities $ 742